Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Travatan

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Objective: To assess symptoms of ocular surface disease (OSD) in patients treated with a BAK-preserved Xalatan (Latanoprost) to… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2012
2012
AbstractBackground Adherence to long-term intraocular pressure (IOP) lowering medication is poor in patients with glaucoma, which… Expand
  • table I
  • figure 1
  • table II
Is this relevant?
2011
2011
PURPOSE To determine the element that modulates benzalkonium chloride (BAC) toxicity by using a new electrophysiological method… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
PURPOSE To evaluate the safety and efficacy of timolol 0.5%/travoprost 0.004% combination (duotrav) as observed in primary open… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
2010
2010
PURPOSE To quantify the aqueous humor (AH) concentrations of bimatoprost (amide), travoprost (isopropyl ester), and their… Expand
Is this relevant?
2010
2010
Purpose The toxicity of antiglaucoma medications to ocular surface cells has been evaluated extensively; however, the toxicity to… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2010
2010
PURPOSE This study evaluated the cytotoxicity of five prostaglandin analog ophthalmic solutions on four ocular surface cell lines… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2006
2006
The aim of investigation was to study the effect of travatan on intraocular pressure (IOP) in patients with primary open-angle… Expand
Is this relevant?